"The US Food and Drug Administration (FDA) has approved Akorn Inc's phenylephrine hydrochloride ophthalmic solution (2.5% and 10%), the company has announced.
The alpha-1 adrenergic receptor agonist is commonly used by optometrists, ophtha"...
DOSAGE AND ADMINISTRATION
Instill one drop of BETOPTIC S® (betaxolol hydrochloride ophthalmic suspension) Ophthalmic Suspension 0.25% in the affected eye twice daily. It may be used alone or in combination with other intraocular pressure lowering medications.
Dosage Forms And Strengths
Bottle filled with 2.5, 5, 10, and 15 mL of 0.25% sterile ophthalmic suspension
BETOPTIC S® (betaxolol hydrochloride ophthalmic suspension) Ophthalmic Suspension 0.25% is supplied as follows: 2.5, 5, 10 and 15 mL in plastic ophthalmic DROP-TAINER® dispensers. Tamper evidence is provided with a shrink band around the closure and neck area of the DROP-TAINER package.
2.5 mL: NDC 0065-0246-20
5 mL: NDC 0065-0246-05
10 mL: NDC 0065-0246-10
15 mL: NDC 0065-0246-15
Storage and Handling
Store upright at 2°- 25°C (36°- 77°F). Shake well before using.
Alcon Laboratories, Inc. Fort Worth, Texas 76134. FDA Rev date: 5/8/2008This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 2/14/2017
Additional Betoptic S Information
Betoptic S - User Reviews
Betoptic S User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get breaking medical news.